KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in IntangiblesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Astrazeneca (AZN) over the last 15 years, with Q4 2025 value amounting to -$251.0 million.

  • Astrazeneca's Change in Intangibles fell 161.94% to -$251.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.1 billion, marking a year-over-year decrease of 1626.6%. This contributed to the annual value of -$3.1 billion for FY2025, which is 1626.6% down from last year.
  • As of Q4 2025, Astrazeneca's Change in Intangibles stood at -$251.0 million, which was down 161.94% from -$1.0 billion recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's Change in Intangibles peaked at -$65.0 million during Q2 2021, and registered a low of -$1.3 billion during Q2 2025.
  • For the 5-year period, Astrazeneca's Change in Intangibles averaged around -$546.0 million, with its median value being -$342.5 million (2021).
  • Per our database at Business Quant, Astrazeneca's Change in Intangibles plummeted by 74930.56% in 2023 and then surged by 5454.55% in 2025.
  • Quarter analysis of 5 years shows Astrazeneca's Change in Intangibles stood at -$395.0 million in 2021, then increased by 26.58% to -$290.0 million in 2022, then rose by 26.55% to -$213.0 million in 2023, then dropped by 15.96% to -$247.0 million in 2024, then fell by 1.62% to -$251.0 million in 2025.
  • Its Change in Intangibles stands at -$251.0 million for Q4 2025, versus -$1.0 billion for Q3 2025 and -$1.3 billion for Q2 2025.